Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Virus-Vectored Oral Rabies Vaccine Bait – Sachet Formulation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract is for the supply of coated sachet vaccine baits designated as part number 128370, specifically formulated for oral rabies vaccination of wildlife populations. These baits are intended to be distributed in targeted areas to immunize terrestrial wildlife against rabies, leveraging a virus-vectored platform to ensure effective delivery and immune response. The product is a sachet formulation designed for environmental stability and animal acceptance, with coating mechanisms to protect the vaccine until consumed. The solicitation is categorized as a subcontract under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, indicating the technical and regulatory rigor expected in production and quality control. Delivery and performance of the vaccine baits must occur within the designated place of performance in Concord, New Hampshire, with a response deadline set for September 7, 2026, and the opportunity posted on August 6, 2026. The contracting entity is the USDA’s Animal and Plant Health Inspection Service Wildlife Services division, reflecting the federal commitment to zoonotic disease control and wildlife health management.

General Info

Supply of coated rabies vaccine baits for wildlife, delivered in Concord, NH by September 7, 2026, under USDA Wildlife Services.

Agency

Department Of Agriculture → Aphis-WsView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Concord, NH, 03301, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Agriculture → Aphis-Ws
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Agriculture → Aphis-Ws
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of coated sachet vaccine baits (part number 128370) for oral rabies vaccination of wildlife.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.
National Institutes Of Health Nida

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
Federal
Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.
National Institutes Of Health Nida

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
Federal
Virus-Vectored Oral Rabies Vaccine Bait – Fishmeal Polymer FormulationThe contract pertains to the supply of fishmeal polymer-based vaccine baits with part number 128425, specifically formulated as a virus-vectored oral rabies vaccine intended for targeted wildlife species. These baits are designed to deliver rabies immunization in a palatable, durable form that supports effective distribution in野外 environments, leveraging a fishmeal polymer matrix to ensure stability and attraction for target animals. The work under this subcontract is tied to efforts led by the USDA’s APHIS-Wildlife Services division to manage and reduce the spread of rabies among wildlife populations through strategic oral vaccination campaigns. The solicitation was posted on August 6, 2026, with submissions due by September 7, 2026, at 9:00 PM. The North American Industry Classification System code 325412 indicates the work falls under pharmaceutical and biological product manufacturing, underscoring the scientific and regulatory rigor expected in production. Performance is required to occur in Concord, New Hampshire, with a ZIP code of 03301, though no specific office address or point of contact is provided. The nature of the contract as a subcontract suggests it supports a broader federal wildlife health initiative, likely underpinning national or regional rabies control programs managed by the Department of Agriculture.
Aphis-Ws

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 325412
New
Federal
SUPPLY AND DELIVERY OF MEDICAL SUPPLIES
Solicitation # 19RP3826Q0059
The U.S. Department of State through the U.S. Embassy Manila is soliciting quotations for the supply and delivery of medical supplies under solicitation number 19RP3826Q0059, with a NAICS code of 325412. Offerors must submit their proposals electronically by August 10, 2026, at 4:00 p.m. Philippine local time, using MS-Word 2007/2010, MS-Excel 2007/2010, or Adobe Acrobat PDF formats, with individual files not exceeding 10MB; larger submissions must be split into multiple emails each under the size limit. Proposals must be in English and include the completed SF-1449 form, Section I Pricing, Section 5 Representations and Certifications, and any additional requirements outlined in Section 3 of the solicitation. All offerors must be registered in the System for Award Management (SAM) prior to submission, as mandated by FAR 4.1102, and failure to register will result in non-responsibility determination. Questions regarding the solicitation must be submitted in writing to ManilaContracting@state.gov no later than July 17, 2026, at 4:00 p.m. Philippine local time. The government intends to award a contract to the responsible vendor submitting the lowest priced acceptable offer, potentially holding discussions only if necessary. No details on delivery schedules, inspection criteria, packaging specifications, or evaluation factors are provided in the available documentation.
US Embassy Manila

POSTED

1 day ago

DEADLINE

in 17 days
View Details
NAICS: 325412
New
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9402
The Department of War, through the Defense Health Agency, is soliciting quotes under RFQ HT9402-26-Q-9402 to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by 10 U.S.C. § 1074g and 32 CFR § 199.21. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine placement on the Uniform Formulary as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary, with the goal of optimizing pharmaceutical procurement through Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Four newly approved drugs—Awiqli Flextouch (basal insulin), Cavhanza (BCR-ABL tyrosine kinase inhibitor for leukemia and lymphoma), Lipfendra (PCSK9 antilipidemic), and Trutakna (nephrology agent)—are scheduled for review at the November 2026 Pharmacy and Therapeutics Committee meeting, and industry responses will inform their inclusion or exclusion. Responses to the RFQ are due by August 27, 2026, with a pre-quotation teleconference scheduled for August 12, 2026, to clarify requirements. Clinical data submissions for evaluation must be sent via email to the designated point of contact by the deadline specified in Part 2.3.2. The solicitation, issued by the Defense Health Agency under NAICS code 325412, is managed from Aurora, Colorado, with performance centered in San Antonio, Texas. Primary contact is Julia Trang, with Stephanie Erpelding as secondary contact, and all submissions and inquiries must adhere to the instructions outlined in RFQ HT9402-26-Q-9402 to be considered valid.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in 20 days
View Details
NAICS: 325412
New
Federal
RABORAL VRG RACCOON BAITS, COATED SACHETS
Solicitation # 1171341
The U.S. Department of Agriculture, Animal and Plant Health Inspection Service (APHIS), through its Wildlife Services program, is seeking to procure up to 6,965,000 units of RABORAL V-RG® oral rabies vaccine baits under a firm fixed price IDIQ contract with a one-year period of performance, covering ordering from September 10, 2026, through September 30, 2027. The contract requires the delivery of two licensed bait types: the coated sachet (part number 128370) in a quantity of 6,915,000 units and the fishmeal polymer (part number 128425) in a quantity of 50,000 units, both manufactured by Boehringer-Ingelheim Animal Health USA, Inc. and containing a live recombinant vaccine that uses an attenuated Vaccinia virus to deliver the rabies glycoprotein gene, which is capable of inducing protective immunity in carnivore wildlife without causing rabies. In addition to bait delivery, the contractor must maintain a segregated, secure, and environmentally controlled storage facility at 115 Transtech Drive, Athens, Georgia, with the capacity to store up to four million baits at any time for no longer than 12 months, under strict temperature monitoring and pest control protocols, and in full compliance with all federal regulations for veterinary biological products. All shipments must be delivered FOB destination to CONUS locations designated at the time of order, with shipping costs included in the unit price. The contract imposes stringent technical and regulatory requirements, including proof of an active USDA CVB license, adherence to current Good Manufacturing Practices, validated cold chain logistics, and demonstrable surge capacity to respond to urgent rabies control needs. Evaluation is based on technical and regulatory compliance, manufacturing and supply chain quality, past performance on similar biological products, and price realism, with licensure serving as a mandatory pass/fail gate. Offers must be submitted by September 7, 2026, at 1700 ET to todd.k.bierl@usda.gov, cannot exceed 100 pages, and will not be accepted if late. The offeror must also comply with numerous federal representation and certification requirements, including those related to tax liability, inverted domestic corporations, drug trafficking, Buy American provisions, anti-discrimination laws, and DEI compliance, and certify that no subcontract
Aphis-Ws

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 325412
New
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9401
The Department of War, through the Defense Health Agency, is soliciting quotations to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by federal law and regulation. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine their placement on the formulary tiers—generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary—with the goal of optimizing patient access and managing expenditures. The solicitation includes the potential award of Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements contingent upon the Pharmacy and Therapeutics Committee’s recommendations. Two drug classes are under review for the November 2026 meeting: Atopy—Topical Agents including Anzupgo, Eucrisa, Opzelura, Vtama, and Zoryve; and Lung Cancer—METEX14, including Tabrecta and Tepmetko. The request for quotation, identified as HT9402-26-Q-9401, outlines detailed procedures, appendices for BPA and ADP, and key submission deadlines. Responses are required by October 1, 2026, with a mandatory pre-quotation teleconference scheduled for August 12, 2026. The solicitation is issued by the Defense Health Agency under the Department of Defense, with the primary point of contact located in Aurora, Colorado, and performance expected in Texas. Vendors must adhere strictly to the instructions provided in the RFQ to ensure eligibility for consideration under the uniform formulary program, which directly impacts pharmacy benefits for military personnel and their dependents.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in about 2 months
View Details

More opportunities from Department Of Agriculture → Aphis-Ws

Same awarding agency